Center for Pharmaceutical Policy and Prescribing
@PittCP3
Followers
1K
Following
2K
Statuses
2K
Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Our research helps improve quality, safety, & efficiency of medication use.
Pittsburgh, PA
Joined May 2018
CP3 folks conduct innovative research that impacts policies & prescriber decisions. Now you can support our mission! Any donation helps us take the next step toward safe, high quality medications for all.
0
3
4
This study examined @WHO recommended National Action Plan post-implementation changes in antibiotic utilization among 38 countries. Authors include @Mina__T & CP3's Tate Miner, @CallawayKim4, & @Sudamonas Presented @IDWeekmtg & pub in @OFIDJournal
0
1
1
This study compared measures for identifying dementia and cognitive impairment in older veteran nursing home residents and found consistency & utility among them. With CP3's @TomRadomskiMD
0
0
0
The HumAn-1 trial is a complex project that's collecting evidence for efficacy of insulin glargine for youth with Type 1 Diabetes living in low resource settings. It's a successful collaboration among CP3 researchers, @BrighamResearch, @LSHTM, Clinton Health Access Initiative, @lifeforachild, & study staff in 🇧🇩&🇹🇿. Read the study protocol @BMJ_Open
0
2
3
Tomorrow starts #NationalHeartMonth! ✅out recent papers from our folks that help prescribers make more informed decisions for🫀health.
0
1
1
This team found3⃣trajectories of potentially nephrotoxic💊use among older adults with T2 Diabetes. Social & clinical factors were associated with 💊use. With CP3's Dr. Kangho Suh & CP3 alums @Serena_JG & @ihdezdelso More in Pharmacoepidemiology & Drug Safety:
0
0
3
CP3 faculty affiliate, @UPittNursing faculty, & clinician-scientist @SarahMBelcher studies the variety of factors that affect adherence to oral anticancer medications. Learn more about Dr. Belcher & her work👇, & don't miss her seminar 2/21! @PittHealthSci
0
0
0
CP3’s @TimAndersonMD is a publishing superstar this month!
🚨 New in @JAMA_current 🚨 We examine trends in preventative aspirin use following changes to no longer routinely recommend aspirin for primary prevention 1/2
0
2
3
This analysis estimates coding inflation rates for MA contracts; payment rates incentivize more intensive coding. Authors (w/ CP3's @TimAndersonMD) found higher coding intensity for health plans that were HMOs, provider-owned, large, older, or had high⭐️ratings. More @Health_Affairs Scholar:
0
1
1
Compound pharmacies help alleviate shortages of GLP-1 Receptor Agonists. CP3 faculty affiliate Dr. Julie Donohue underscores the need for greater clarity & oversight from @US_FDA to inform & protect consumers. More in @JAMAHealthForum
0
1
2
Ethics and AI are in the news lately. Our team spends a lot of time thinking about ethics in all stages of AI-based clinical decision support tools. ICYMI: our experts describe how to use human factors to mitigate bias. @walidgellad @jennyciganic Read @AMIAinformatics
0
1
0
ICYMI: CP3's @NoahMFeder & Dr. Jing Luo analyzed glucagon prescriptions over time, focusing on periods before and after 2018, when new glucagon products entered the market. Read @Medscape summary of the paper, originally published in @JAMA_current 👇
0
0
0
Jan 12 was #NationalPharmacistDay. Pharmacists are always part of Team CP3, and we believe they're key members of a patient's care team. Thank you, pharmacists!
0
0
1
In a new study, CP3's @jennyciganic & team determined that Anti-CGRP mAbs didn't appear to ⬆️CVD risk compared with onabotulinumtoxinA among Medicare beneficiaries with migraine. Read more @JAMANeuro
0
3
1
Glucagon is recommended for severe hypoglycemia, yet fill rates are low. A🆕study examined Rx & reimbursement trends in glucagon products before & after introduction of newer products in recent years. With CP3's @NoahMFeder & Dr. Jing Luo Read more @JAMA_current
0
2
2
RT @TimAndersonMD: 🔥New in @JournalGIM🔥 Industry Payments to Physicians During Medical Specialty Society Conferences - Using an event stu…
0
5
0
CP3's @TimAndersonMD spoke with @statnews about the PREVENT model, a simpler, less expensive way to predict risk of heart failure. @PittGIM @PittDeptofMed @PittHealthSci
0
3
2
#Pharmacoequity is key to reducing health disparities. To help achieve this goal, Drs. Pranav Patel, Laura Happe, & CP3 alum @UREssien developed a framework to measure RxEquity domains. Read more @amcporg #JMCP CP3's RxEquity work:
0
1
2
We're on break until 2025. Wishing everyone light and peace this holiday season.
0
0
1
We can’t forget our friends & followers on X & Bluesky. Our accounts posted 400 times on both platforms in 2024! Thank you for amplifying the work we do! Looking forward to new connections in 2025! 7/7
0
0
0